Combination Approach for the Management of Psoriasis

Preview this chapter:

Combination Approach for the Management of Psoriasis, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9798898812737/chapter-3-1.gif

Psoriasis is a prominent autoimmune condition characterized by an abnormal increase in the production of skin cells, leading to the formation of thick, red, and scaly patches on the skin. Comprehending the intricate pathophysiology of this condition, which involves the deregulation of the immune system and inflammatory processes, is essential for the development of efficacious treatments. Existing treatment modalities, such as monotherapy, have inherent constraints in effectively managing psoriasis of moderate to severe intensity, resulting in persistent symptoms and reduced responsiveness to treatment. Therefore, using a combination strategy that focuses on various disease-causing pathways provides improved effectiveness in treatment, decreases the development of resistance, and improves patient outcomes. Nevertheless, it is crucial to carefully evaluate issues such as personalized treatment regimens, adherence to therapy, economic factors, and the handling of medication interactions and toxicities. Customized treatment methods, novel combination medications, and integrated therapy platforms have the potential to maximize psoriasis control. Thorough and personalized combination approaches hold great promise for improving the quality of life for individuals with psoriasis.